Epizyme, Inc.
Clinical trials sponsored by Epizyme, Inc., explained in plain language.
-
Major trial aims to control stubborn blood cancer
Disease control Recruiting nowThis large, late-stage trial is testing whether adding a new drug called tazemetostat to a standard two-drug treatment helps people with follicular lymphoma live longer without their cancer getting worse. The study is for adults whose lymphoma has returned or stopped responding t…
Phase: PHASE3 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test if damaged livers change cancer drug effects
Knowledge-focused Recruiting nowThis early study aims to understand how liver problems affect the way the body processes a cancer drug called tazemetostat. It will compare blood levels of the drug in people with advanced cancer who have normal liver function to those with moderate or severe liver impairment. Th…
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC